10X Genomics Inc
10xgenomics.com10X Genomics Inc (NASDAQ: TXG) is a life sciences tools company that develops and sells instruments, consumables, and software for single-cell and spatial genomics analysis. Revenue comes primarily from the sale of instruments placed in research laboratories and the recurring consumables those instruments require for each experiment, creating a razor-and-blade revenue structure. The company serves academic research institutions, biopharma companies, and other life sciences organizations globally. As of the 10-K filed February 13, 2026, 10X Genomics had completed the acquisition of Scale Biosciences, Inc., expanding its single-cell product portfolio. The company carries dual-class common stock, with Class A and Class B shares outstanding as of January 31, 2026. 10X Genomics does not pay a dividend and has historically operated at a net loss while investing heavily in product development and commercial expansion.
Products & Services
Single-cell genomics instruments and consumables; spatial genomics instruments and consumables; analysis software; products from acquired Scale Biosciences, Inc.
Revenue Model
Instrument sales combined with high-margin recurring consumables sales tied to installed instrument base, creating a razor-and-blade structure. Software may accompany instrument and consumable sales.
Customers & Markets
Academic and government research institutions; biopharmaceutical and biotechnology companies; life sciences researchers conducting single-cell and spatial biology experiments.
Geographic Exposure
Global operations; specific regional revenue breakdown not supported by available filing excerpts.
Financial Snapshot
Loading...
